MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 253 filers reported holding MYRIAD GENETICS INC in Q1 2015. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,997,000 | -20.3% | 65,256 | -11.4% | 0.14% | +11.4% |
| Q4 2014 | $2,507,000 | -19.2% | 73,616 | -8.5% | 0.12% | -19.6% |
| Q3 2014 | $3,104,000 | +11.1% | 80,476 | +12.1% | 0.15% | -5.6% |
| Q2 2014 | $2,794,000 | +14.2% | 71,778 | +0.3% | 0.16% | +1.2% |
| Q1 2014 | $2,447,000 | +23.5% | 71,576 | -24.2% | 0.16% | +28.0% |
| Q4 2013 | $1,982,000 | -32.5% | 94,466 | -24.4% | 0.12% | -37.5% |
| Q3 2013 | $2,936,000 | – | 124,941 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,500,000 | $134,530 | 3.72% |
| Glenview Capital Management | 3,748,432 | $91,686,647 | 1.80% |
| ORACLE INVESTMENT MANAGEMENT INC | 60,000 | $1,467,600 | 1.37% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 240,128 | $5,873,531 | 1.10% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,087,328 | $51,056,043 | 0.96% |
| OBERWEIS ASSET MANAGEMENT INC/ | 360,700 | $8,822,722 | 0.54% |
| EARNEST PARTNERS LLC | 4,072,018 | $99,601,560 | 0.47% |
| AIMZ Investment Advisors, LLC | 39,585 | $968,249 | 0.35% |
| Eversept Partners, LP | 181,961 | $4,450,766 | 0.30% |
| Hillsdale Investment Management Inc. | 151,180 | $3,697,863 | 0.29% |